Dr. Vladimir Hugec, MD

Dr. Hugec practices at Minnesota Oncology Hematology, PA in Saint Paul, Minnesota.

Dr. Hugec's NPI, 1790723328, was assigned on June 4, 2006. Dr. Hugec graduated from Pavol Jozef Safarik University Faculty of Medicine in 1994. Dr. Hugec's Minnesota license number on file is 48469.

Dr. Hugec's primary practice is Minnesota Oncology Hematology, PA, at 1580 Beam E Ave, Saint Paul, MN 55109 in Ramsey County. The practice phone is (651) 779-7978.

Dr. Hugec's primary practice is Minnesota Oncology Hematology, PA in Saint Paul, Minnesota. Dr. Hugec is also affiliated with United Hospital. The medical group on file is Buffalo Hospital. Dmand AI also links Dr. Hugec to 4 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hugec practices, 7 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Hugec's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Hugec is board certified in medical oncology by the American Board of Internal Medicine. Dmand AI has Dr. Hugec's licenses on file in 3 states: Minnesota, Wisconsin and Iowa.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, lung cancer, lymphoma, multiple myeloma and prostate cancer among the conditions Dr. Hugec treats.

CMS data shows 153,209 Medicare services from Dr. Hugec across 82 procedure codes in 2024, for 624 Medicare patients. Medicare paid $2,324,221 for them. Every service was in an office.

CMS counts 624 Medicare patients who saw Dr. Hugec in 2024. The largest group is 65 to 74, with 293 patients. 70% of them have cancer, and 68% have high blood pressure. 6% are also on Medicaid. Their average risk score is 2.47, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hugec's median patient age at 72, with 33% women.

In 2024, Dr. Hugec wrote 4,047 Medicare Part D claims for 484 patients. 57% of them were for generic drugs. CMS names the drug for 3,790 of them, across 55 drugs with 11 or more claims each, at $19,406,281 in total drug cost. In 2023, CMS named 2,868 claims across 48 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Hugec for performance year 2024, reported through an alternative payment model (APM). Dr. Hugec accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Hugec as offering telehealth.

Dmand AI links 4 papers to Dr. Hugec in 2012. 2012 was the busiest year, with 2. The most frequent topics are Adenocarcinoma. Dr. Hugec's most frequent co-authors are Athanassios Argiris, MD, Netta M. Blitman, MD and Frederick W. Endorf, MD.

CMS Open Payments shows 53 general payments to Dr. Hugec from 12 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 52% of the total. Pharmacyclics LLC, An AbbVie Company paid the most, $6,009.

Dmand AI lists 1 award for Dr. Hugec, most recently CMS Stage 1 2012 in 2012.

Dr. Hugec graduated from Pavol Jozef Safarik University Faculty of Medicine in 1994. Dr. Hugec is a member of ASCO.

Dr. Hugec is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Medica. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.